Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Food Industry News Pinnacle Asset Management’s Viserion Grain acquires major grain elevator assets Pinnacle Asset Management, L.P., a prominent New York-based firm specialising in alternative asset management with a focus on… byPallavi MadhirajuJuly 28, 2024